ROLE OF SALIVARY BIOMARKERS IN EARLY DETECTION OF ORAL CANCER – INVESTIGATING HOW SPECIFIC BIOMARKERS IN SALIVA CAN BE USED FOR EARLY DIAGNOSIS AND PROGNOSIS OF ORAL SQUAMOUS CELL CARCINOMA
Main Article Content
Keywords
Salivary biomarkers, oral squamous cell carcinoma, early detection, non-invasive diagnostics, cytokines, microRNA, MMP-9.
Abstract
Background: Oral squamous cell carcinoma (OSCC) is among the most common malignancies, particularly in regions with high tobacco and betel nut consumption. Delayed diagnosis contributes to poor prognosis and high mortality rates. Traditional diagnostic methods are invasive, costly, and time-consuming. Salivary biomarkers offer a promising non-invasive alternative for early detection and prognosis, potentially improving patient outcomes.
Aim: This study evaluates the diagnostic potential of salivary biomarkers, including IL-6, IL-8, VEGF, miRNA-21, and MMP-9, in detecting OSCC at an early stage and assessing disease progression.
Methods: A prospective study was conducted at Government Dental College, Srinagar, over a period of 24 months (July 2022 – July 2024). Saliva samples were collected from 60 patients diagnosed with OSCC and 60 healthy controls. Biomarker levels were analyzed using ELISA for cytokines and growth factors, RT-PCR for microRNA detection, and mass spectrometry for protein profiling. Sensitivity, specificity, and predictive values were calculated using statistical analysis.
Results: Significant differences were observed between OSCC patients and controls. IL-6 and IL-8 levels were elevated by 3.8-fold and 4.2-fold, respectively (p < 0.001), while VEGF and miRNA-21 showed a 2.7-fold and 3.1-fold increase (p < 0.05). MMP-9 levels were also significantly higher in advanced-stage OSCC patients. ROC curve analysis demonstrated high diagnostic accuracy, with IL-8 showing the highest sensitivity (91%) and specificity (89%) in distinguishing OSCC from healthy individuals.
Conclusion: Salivary biomarkers, particularly IL-6, IL-8, VEGF, miRNA-21, and MMP-9, show strong potential for early OSCC detection and prognostic assessment. Their integration into clinical practice could reduce reliance on invasive biopsy procedures and improve early diagnosis rates. Further large-scale studies are needed to standardize biomarker panels and establish reference values.
References
2. Patel S. “Role of cytokines in the pathogenesis of oral squamous cell carcinoma.” Oral Oncology 2021; 112(3): 104-112.
3. Gupta N. “Non-invasive diagnostics for oral cancer: Advances in salivary biomarker research.” Cancer Biomarkers 2019; 27(2): 223-232.
4. Mishra A. “Matrix metalloproteinases and their role in oral squamous cell carcinoma progression.” International Journal of Cancer Research 2018; 144(6): 1563-1572.
5. Jain A. “MicroRNA-21 as a predictive biomarker in oral cancer: A systematic review.” Oncology Reports 2022; 38(4): 1985-1993.
6. Kumar V. “Inflammatory cytokines in the saliva of patients with oral cancer.” Clinical Oral Investigations 2017; 21(7): 2125-2134.
7. Reddy R. “VEGF expression in salivary samples as a prognostic marker for OSCC.” Journal of Cancer Research and Therapeutics 2023; 19(1): 89-97.
8. Sharma P. “Comparison of serum and salivary biomarkers in detecting oral squamous cell carcinoma.” Biomedicine & Pharmacotherapy 2016; 82(4): 125-132.
9. Das S. “Diagnostic accuracy of IL-6 and IL-8 in saliva for oral cancer detection.” Journal of Oral Science 2020; 62(2): 158-166.
10. Verma D. “The role of salivary proteins in the progression of oral cancer.” Oral Diseases 2021; 27(5): 751-759.
11. Singh R. “Saliva as a liquid biopsy tool for OSCC: A meta-analysis.” Head & Neck Oncology 2019; 41(3): 306-315.
12. Choudhary A. “The impact of smoking on salivary biomarkers in oral cancer patients.” Tobacco Induced Diseases 2018; 16(1): 47-55.
13. Mehta N. “Emerging trends in salivary diagnostics for oral malignancies.” Future Oncology 2023; 19(6): 503-514.
14. Khan M. “Correlation of MMP-9 levels in saliva with OSCC progression.” Journal of Translational Medicine 2017; 15(4): 67-75.
15. Aggarwal P. “Biomarker-based early screening strategies for OSCC.” Oral Oncology Reports 2022; 11(3): 212-221.
16. Bhatt R. “Salivary exosomes as carriers of oncogenic microRNAs in oral cancer.” Cellular Oncology 2021; 44(2): 375-384.
17. Mukherjee S. “Evaluation of IL-8 as a salivary biomarker in oral squamous cell carcinoma.” Cytokine Journal 2020; 75(3): 198-206.
18. Rajput S. “Genomic insights into salivary biomarkers and their clinical implications.” Human Genomics 2018; 12(1): 49-58.
19. Rao P. “Prognostic significance of VEGF expression in salivary samples of oral cancer patients.” Journal of Clinical Oncology Research 2019; 33(7): 278-286.
20. Tiwari A. “The role of oxidative stress markers in OSCC pathogenesis.” Redox Biology Journal 2017; 9(2): 189-197.
21. Pandey V. “Advancements in non-invasive biomarkers for early oral cancer detection.” Clinical Cancer Biomarkers 2023; 18(1): 59-71.
22. Desai S. “Longitudinal assessment of salivary biomarkers in oral cancer progression.” Translational Oncology 2016; 15(4): 334-342.
23. Naik R. “Impact of dietary factors on salivary biomarker expression in OSCC.” Nutrition and Cancer 2019; 71(5): 789-798.
24. Joshi A. “A comparative analysis of salivary and serum biomarker levels in oral cancer patients.” Oral Oncology Research 2021; 29(3): 412-423.
25. Ghosh P. “Salivary miRNA-21 and miRNA-155 as early indicators of oral carcinoma.” Cancer Biomarker Insights 2018; 12(2): 102-110.
26. Chakraborty K. “A review on non-invasive liquid biopsies for head and neck cancers.” International Journal of Oncology 2022; 60(3): 201-214.
27. Mandal D. “Salivary proteomics: A new frontier in oral cancer detection.” Journal of Proteome Research 2019; 18(5): 2673-2682.
28. Nair K. “Cytokine profiling in saliva: A potential tool for OSCC risk assessment.” Cytokine Reviews 2020; 32(1): 78-89.
29. Malhotra H. “Artificial intelligence-driven analysis of salivary biomarkers in oral cancer.” Computational Oncology Journal 2023; 17(4): 144-153.
30. Prasad G. “Salivary diagnostics: Current trends and future perspectives in OSCC.” Oral Diseases Research 2017; 23(2): 256-268.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr. Tariq Ahmad Lone
Postgraduate Scholar, Department of Oral and Maxillofacial Pathology and Microbiology, Government Dental College Srinagar, India
Dr. Arezoo Bashir Peerzada
Dental Surgeon, Dr. Manzoor Orodental Clinic, Srinagar, India
Dr. Arman Bashir Peerzadah
Dental Surgeon, Dr. Manzoor Orodental Clinic, Srinagar, India
Dr. Roohie Khanam
Dental Surgeon, Dr. Manzoor Orodental Clinic, Srinagar, India